Concept
Audio mixing
Related people (27)
Thierry Meyer
Thierry Meyer received in 1986 a diploma degree (MSc) in chemical engineering from the Swiss Federal Institute of Technology at Lausanne (EPFL). He was awarded in 1989 a PhD at EPFL for his thesis on micromixing in highly viscous polymeric media. He joined the Institute of Chemical Engineering from 1989 till 1993 as senior scientist in the field of polymerization reactions. In 1994 he joined Ciba-Geigy SA in the pigment division as successively development chemist, head of development a.i. and finally production manager for high performance pigments. Returning to the Institute of Chemical Engineering at EPFL in Lausanne by the end of 1998, he was nominated maître denseignement et de recherche (MER) for leading a new research group in the field of polymers and supercritical fluids, and teaching to chemists, chemical engineers and material sciences, disciplines as process development, introduction to chemical engineering, polymer and organic chemistry at master and bachelor program. In 2005 he owned the responsibility of the Occupational Health and Safety of the school of basic sciences on top of his research activities dealing with risk management and supercritical fluids. He is presently teaching introduction to chemical engineering at bachelor level, risk management at master level and specific courses on safety and engineering risk management in continuing education. He acts also as consultant and expert in risk assessment and chemical engineering matters by the ICC (International Chamber of Commerce) of the World Business Organization, by several consultancy companies and by major and SMEs chemical industries. Thierry Meyer is currently member of several international associations of the European Federation of Chemical Engineering, American institution of chemical engineering, American chemical society and senior member of the American Institute of Chemical Engineers. He was elected chairman of the European Working Party on Polymer Reaction Engineering from 2001 till 2006. He his currently the Swiss academic member of the European Working Party on Loss Prevention and Safety Promotion as well as of the European Working Party on Education. He is member of several editorial boards: Chemical Engineering Research and Design, Macromolecular Reaction Engineering, Chemical Engineering and Technology, Journal of Chemical Health and Safety.
Karen Scrivener
De nationalité anglaise, Karen Scrivener est née en 1958. Au cours de sa carrière, ses travaux et sa recherche traitaient des domaines suivants: Identification du développement microstucturale pendant l'hydratation du ciment. Elaboration d'une approche multitechnique pour étudier la microstucture des ciments et bétons, avec accent sur la quantification par analyse des images d'électrons retrodiffusés. Caractérisation de l'auréole de transition de la pâte de ciment autour des granulats. Compréhension des processus de dégardation des bétons, en particulier le gonflement lié à la formation de l'éttringite retardée dans les bétons étuvés.
Olivier Schneider
After his thesis defense in particle physics in 1989 at University of Lausanne, Olivier Schneider joins LBL, the Lawrence Berkeley Laboratory (California), to work on the CDF experiment at the Tevatron in Fermilab (Illinois), first as a research fellow supported by the Swiss National Science Foundation, and later as a post-doc at LBL. He participates in the construction and commissioning of the first silicon vertex detector to operate successfully at a hadron collider; this detector enabled the discovery of the sixth quark, named "top". Since 1994, he comes back to Europe and participates in the ALEPH experiment at CERN's Large Electron-Positron Collider, as CERN fellow and then as CERN scientific staff. He specializes in heavy flavour physics. In 1998, he becomes associate professor at University of Lausanne, then extraordinary professor at the Swiss Institute of Technology Lausanne (EPFL) in 2003, and finally full professor at EPFL in 2010. Having worked since 1997 on the preparation of the LHCb experiment at CERN's Large Hadron Collider, which started operation in 2009, he is now analyzing the first data. He also contributes since 2001 to the exploitation of the data recorded at the Belle experiment (KEK laboratory, Tsukuba, Japan). These two experiments study mainly the decays of hadrons containing a b quark, as well CP violation, i.e. the non-invariance under the symmetry between matter and antimatter.
Florian Maria Wurm
Florian Wurm received his academic training as a Biologist and Molecular Geneticist at the University of Giessen. He joined the Hoechst AG (Behringwerke) in Marburg as head of a laboratory in Virology. Working with immortalized mammalian cells for the establishment of production processes for alpha-interferons provided the first opportunity to combine basic research with medical application. In 1984 he joined Harvard Medical School in Boston as a Research Fellow in Molecular Biology. 1986 he took an offer from Genentech Inc. in San Francisco to work in Process Sciences on the development of large scale manufacturing processes for recombinant proteins. There he has held a number of leading positions and has acquired intimate knowledge in the generation of protein pharmaceuticals in mammalian cells in bioreactors (a number of which are now marketed products). In 1995 he joined the EPFL as a Professor for Biotechnology. Wurm has published more than 250 scientific papers and holds more than 20 patents/patent-applications. His H-index stands at 60 in 2021. He was Chairman (2005-2009) and is member of the Executive Board of the European Society of Animal Cell Technology (ESACT). He serves as a consultant to the pharmaceutical Biotech Industry, mainly in the fields of animal cell technology for recombinant protein production and in regulatory affairs. He works as a scientific reviewer and editior/asscciate editor for a number of international journals in the Biotech field. F.M. Wurm teaches classes to pre- and postgraduate students in the fields of Molecular and Cellular Biotechnology.
He was founder and Chief Scientific Officer of ExcellGene SA, a 2001 established company in Monthey, Switzerland. He took the position of President and CEO of ExcellGene in 2015. He retired from the CEO position in 2017 and continues to be President and Chief Scientific Officer of ExcellGene.
In 2008 Dr. Wurm was appointed Visiting Professor for Biotechnology at Jinan University in Guangzhou, China. He retired from his position at the EPFL in 2015. His laboratory is closed. With his team at ExcellGene and in collaboration with Dr. Paco Pino, Director of R&D, he continues to explore manufacturing sciences with animal cells in bioreactors.